Abstract
According to the recommendations of the European Society of Hypertension/European Society of Cardiology guidelines on the diagnosis and management of hypertension, the major benefits of antihypertensive treatment are related to blood pressure reduction per se rather than to the specific drugs used. This article reviews this statement by discussing the evidence provided by a number of clinical trials that blood pressure reduction is more important than the antihypertensive drug choice in uncomplicated hypertensive patients. The difference between drugs will become increasingly important as the cardiovascular risk profile of the patient becomes elevated and/or when associated risk factors or concomitant target organ damage are detected.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: High Blood Pressure & Cardiovascular Prevention
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
